{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T11:55:55Z","timestamp":1785758155535,"version":"3.56.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Jiaxing Science and Technology Plan Project","award":["No. 2018AY32044"],"award-info":[{"award-number":["No. 2018AY32044"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s10620-023-08210-x","type":"journal-article","created":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T14:02:43Z","timestamp":1704290563000},"page":"476-490","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Metformin Increases the Response of Cholangiocarcinoma Cells to Gemcitabine by Suppressing Pyruvate Kinase M2 to Activate Mitochondrial Apoptosis"],"prefix":"10.1007","volume":"69","author":[{"given":"Haishan","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongtao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6275-1993","authenticated-orcid":false,"given":"Ping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,3]]},"reference":[{"issue":"2","key":"8210_CR1","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nrclinonc.2017.157","volume":"15","author":"S Rizvi","year":"2018","unstructured":"Rizvi S, Khan SA, Hallemeier CL, Kelley RK, Gores GJ. Cholangiocarcinoma - evolving concepts and therapeutic strategies. Nat Rev Clin Oncol 2018;15:95\u2013111. https:\/\/doi.org\/10.1038\/nrclinonc.2017.157.","journal-title":"Nat Rev Clin Oncol"},{"issue":"Suppl 1","key":"8210_CR2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/liv.14102","volume":"39","author":"L Fouassier","year":"2019","unstructured":"Fouassier L, Marzioni M, Afonso MB et al. Signalling networks in cholangiocarcinoma: Molecular pathogenesis, targeted therapies and drug resistance. Liver Int 2019;39:43\u201362. https:\/\/doi.org\/10.1111\/liv.14102.","journal-title":"Liver Int"},{"issue":"5","key":"8210_CR3","doi-asserted-by":"publisher","first-page":"395","DOI":"10.4161\/cam.26345","volume":"7","author":"T Han","year":"2013","unstructured":"Han T, Kang D, Ji D et al. How does cancer cell metabolism affect tumor migration and invasion? Cell Adh Migr 2013;7:395\u2013403. https:\/\/doi.org\/10.4161\/cam.26345.","journal-title":"Cell Adh Migr"},{"issue":"4","key":"8210_CR4","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.semcdb.2012.02.003","volume":"23","author":"SJ Bensinger","year":"2012","unstructured":"Bensinger SJ, Christofk HR. New aspects of the Warburg effect in cancer cell biology. Semin Cell Dev Biol 2012;23:352\u2013361. https:\/\/doi.org\/10.1016\/j.semcdb.2012.02.003.","journal-title":"Semin Cell Dev Biol"},{"issue":"7","key":"8210_CR5","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.biocel.2010.02.005","volume":"43","author":"S Mazurek","year":"2011","unstructured":"Mazurek S. Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells. Int J Biochem Cell Biol 2011;43:969\u2013980. https:\/\/doi.org\/10.1016\/j.biocel.2010.02.005.","journal-title":"Int J Biochem Cell Biol"},{"key":"8210_CR6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/2789_2008_091","volume":"4","author":"S Mazurek","year":"2007","unstructured":"Mazurek S. Pyruvate kinase type M2: a key regulator within the tumour metabolome and a tool for metabolic profiling of tumours. Ernst Schering Found Symp Proc 2007;4:99\u2013124. https:\/\/doi.org\/10.1007\/2789_2008_091.","journal-title":"Ernst Schering Found Symp Proc"},{"key":"8210_CR7","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.biopha.2018.09.031","volume":"108","author":"C Cheng","year":"2018","unstructured":"Cheng C, Xie Z, Li Y, Wang J, Qin C, Zhang Y. PTBP1 knockdown overcomes the resistance to vincristine and oxaliplatin in drug-resistant colon cancer cells through regulation of glycolysis. Biomed Pharmacother 2018;108:194\u2013200. https:\/\/doi.org\/10.1016\/j.biopha.2018.09.031.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"8210_CR8","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.3892\/ol.2017.7598","volume":"15","author":"S Tian","year":"2018","unstructured":"Tian S, Li P, Sheng S, Jin X. Upregulation of pyruvate kinase M2 expression by fatty acid synthase contributes to gemcitabine resistance in pancreatic cancer. Oncol Lett 2018;15:2211\u20132217. https:\/\/doi.org\/10.3892\/ol.2017.7598.","journal-title":"Oncol Lett"},{"issue":"13","key":"8210_CR9","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.7150\/ijbs.27854","volume":"14","author":"Y Wang","year":"2018","unstructured":"Wang Y, Hao F, Nan Y et al. PKM2 Inhibitor Shikonin Overcomes the Cisplatin Resistance in Bladder Cancer by Inducing Necroptosis. Int J Biol Sci 2018;14:1883\u20131891. https:\/\/doi.org\/10.7150\/ijbs.27854.","journal-title":"Int J Biol Sci"},{"issue":"4","key":"8210_CR10","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1002\/ijc.29564","volume":"138","author":"E Saunier","year":"2016","unstructured":"Saunier E, Benelli C, Bortoli S. The pyruvate dehydrogenase complex in cancer: An old metabolic gatekeeper regulated by new pathways and pharmacological agents. International journal of cancer 2016;138:809\u2013817. https:\/\/doi.org\/10.1002\/ijc.29564.","journal-title":"International journal of cancer"},{"key":"8210_CR11","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.biopha.2017.03.068","volume":"90","author":"S Wei","year":"2017","unstructured":"Wei S, Ma W. MiR-370 functions as oncogene in melanoma by direct targeting pyruvate dehydrogenase B. Biomed Pharmacother 2017;90:278\u2013286. https:\/\/doi.org\/10.1016\/j.biopha.2017.03.068.","journal-title":"Biomed Pharmacother"},{"issue":"11","key":"8210_CR12","doi-asserted-by":"publisher","first-page":"14989","DOI":"10.1007\/s13277-016-5415-1","volume":"37","author":"Z Xiaohong","year":"2016","unstructured":"Xiaohong Z, Lichun F, Na X, Kejian Z, Xiaolan X, Shaosheng W. MiR-203 promotes the growth and migration of ovarian cancer cells by enhancing glycolytic pathway. Tumour biology\u202f: the journal of the International Society for Oncodevelopmental Biology and Medicine 2016;37:14989\u201314997. https:\/\/doi.org\/10.1007\/s13277-016-5415-1.","journal-title":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine"},{"issue":"16","key":"8210_CR13","doi-asserted-by":"publisher","first-page":"5230","DOI":"10.26355\/eurrev_201808_15721","volume":"22","author":"DX Xu","year":"2018","unstructured":"Xu DX, Guo JJ, Zhu GY, Wu HJ, Zhang QS, Cui T. MiR-363-3p modulates cell growth and invasion in glioma by directly targeting pyruvate dehydrogenase B. European review for medical and pharmacological sciences 2018;22:5230\u20135239. https:\/\/doi.org\/10.26355\/eurrev_201808_15721.","journal-title":"European review for medical and pharmacological sciences"},{"issue":"8","key":"8210_CR14","doi-asserted-by":"publisher","first-page":"10563","DOI":"10.1007\/s13277-016-4922-4","volume":"37","author":"H Tang","year":"2016","unstructured":"Tang H, Luo X, Li J et al. Pyruvate dehydrogenase B promoted the growth and migration of the nasopharyngeal carcinoma cells. Tumour biology\u202f: the journal of the International Society for Oncodevelopmental Biology and Medicine 2016;37:10563\u201310569. https:\/\/doi.org\/10.1007\/s13277-016-4922-4.","journal-title":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine"},{"key":"8210_CR15","doi-asserted-by":"publisher","first-page":"170","DOI":"10.5604\/01.3001.0010.3801","volume":"71","author":"M Podhorecka","year":"2017","unstructured":"Podhorecka M, Ibanez B, Dmoszynska A. Metformin - its potential anti-cancer and anti-aging effects. Postepy Hig Med Dosw (Online) 2017;71:170\u2013175. https:\/\/doi.org\/10.5604\/01.3001.0010.3801.","journal-title":"Postepy Hig Med Dosw (Online)"},{"issue":"40","key":"8210_CR16","doi-asserted-by":"publisher","first-page":"66202","DOI":"10.18632\/oncotarget.11033","volume":"7","author":"SJ Ma","year":"2016","unstructured":"Ma SJ, Zheng YX, Zhou PC, Xiao YN, Tan HZ. Metformin use improves survival of diabetic liver cancer patients: systematic review and meta-analysis. Oncotarget 2016;7:66202\u201366211. https:\/\/doi.org\/10.18632\/oncotarget.11033.","journal-title":"Oncotarget"},{"issue":"9","key":"8210_CR17","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1007\/s00125-017-4372-6","volume":"60","author":"BM Heckman-Stoddard","year":"2017","unstructured":"Heckman-Stoddard BM, DeCensi A, Sahasrabuddhe VV, Ford LG. Repurposing metformin for the prevention of cancer and cancer recurrence. Diabetologia 2017;60:1639\u20131647. https:\/\/doi.org\/10.1007\/s00125-017-4372-6.","journal-title":"Diabetologia"},{"issue":"9","key":"8210_CR18","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1158\/2159-8290.CD-12-0263","volume":"2","author":"MN Pollak","year":"2012","unstructured":"Pollak MN. Investigating metformin for cancer prevention and treatment: the end of the beginning. Cancer Discov 2012;2:778\u2013790. https:\/\/doi.org\/10.1158\/2159-8290.CD-12-0263.","journal-title":"Cancer Discov"},{"issue":"9","key":"8210_CR19","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","volume":"60","author":"G Rena","year":"2017","unstructured":"Rena G, Hardie DG, Pearson ER. The mechanisms of action of metformin. Diabetologia 2017;60:1577\u20131585. https:\/\/doi.org\/10.1007\/s00125-017-4342-z.","journal-title":"Diabetologia"},{"issue":"1","key":"8210_CR20","doi-asserted-by":"publisher","first-page":"77","DOI":"10.4161\/15384047.2014.987021","volume":"16","author":"G Han","year":"2015","unstructured":"Han G, Gong H, Wang Y, Guo S, Liu K. AMPK\/mTOR-mediated inhibition of survivin partly contributes to metformin-induced apoptosis in human gastric cancer cell. Cancer Biol Ther 2015;16:77\u201387. https:\/\/doi.org\/10.4161\/15384047.2014.987021.","journal-title":"Cancer Biol Ther"},{"issue":"1","key":"8210_CR21","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12872-020-01359-7","volume":"20","author":"Y Liu","year":"2020","unstructured":"Liu Y, Bai F, Liu N et al. Metformin improves lipid metabolism and reverses the Warburg effect in a canine model of chronic atrial fibrillation. BMC Cardiovasc Disord 2020;20:50. https:\/\/doi.org\/10.1186\/s12872-020-01359-7.","journal-title":"BMC Cardiovasc Disord"},{"key":"8210_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.3029","author":"C Liu","year":"2020","unstructured":"Liu C, Liu Q, Yan A et al. Metformin revert insulin-induced oxaliplatin resistance by activating mitochondrial apoptosis pathway in human colon cancer HCT116 cells. Cancer Med. 2020. https:\/\/doi.org\/10.1002\/cam4.3029.","journal-title":"Cancer Med"},{"issue":"2","key":"8210_CR23","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.clinre.2019.06.008","volume":"44","author":"Z Qian","year":"2020","unstructured":"Qian Z, Hu W, Lv Z et al. PKM2 upregulation promotes malignancy and indicates poor prognosis for intrahepatic cholangiocarcinoma. Clin Res Hepatol Gastroenterol 2020;44:162\u2013173. https:\/\/doi.org\/10.1016\/j.clinre.2019.06.008.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"8210_CR24","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12943-015-0462-6","volume":"14","author":"G Yu","year":"2015","unstructured":"Yu G, Yu W, Jin G et al. PKM2 regulates neural invasion of and predicts poor prognosis for human hilar cholangiocarcinoma. Mol Cancer 2015;14:193. https:\/\/doi.org\/10.1186\/s12943-015-0462-6.","journal-title":"Mol Cancer"},{"key":"8210_CR25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.trsl.2018.07.013","volume":"202","author":"S Pustylnikov","year":"2018","unstructured":"Pustylnikov S, Costabile F, Beghi S, Facciabene A. Targeting mitochondria in cancer: current concepts and immunotherapy approaches. Transl Res 2018;202:35\u201351. https:\/\/doi.org\/10.1016\/j.trsl.2018.07.013.","journal-title":"Transl Res"},{"issue":"11","key":"8210_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0049988","volume":"7","author":"L Wang","year":"2012","unstructured":"Wang L, Shi Y, Ju P et al. Silencing of diphthamide synthesis 3 (Dph3) reduces metastasis of murine melanoma. PloS one 2012;7:e49988. https:\/\/doi.org\/10.1371\/journal.pone.0049988.","journal-title":"PloS one"},{"issue":"2","key":"8210_CR27","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.bpg.2015.02.003","volume":"29","author":"A Bergquist","year":"2015","unstructured":"Bergquist A, von Seth E. Epidemiology of cholangiocarcinoma. Best practice & research Clinical gastroenterology 2015;29:221\u2013232. https:\/\/doi.org\/10.1016\/j.bpg.2015.02.003.","journal-title":"Best practice & research Clinical gastroenterology"},{"issue":"5","key":"8210_CR28","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1038\/s41418-019-0450-2","volume":"27","author":"YY Jing","year":"2020","unstructured":"Jing YY, Cai FF, Zhang L et al. Epigenetic regulation of the Warburg effect by H2B monoubiquitination. Cell death and differentiation 2020;27:1660\u20131676. https:\/\/doi.org\/10.1038\/s41418-019-0450-2.","journal-title":"Cell death and differentiation"},{"issue":"8","key":"8210_CR29","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.tibs.2008.05.006","volume":"33","author":"EC Ferguson","year":"2008","unstructured":"Ferguson EC, Rathmell JC. New roles for pyruvate kinase M2: working out the Warburg effect. Trends in biochemical sciences 2008;33:359\u2013362. https:\/\/doi.org\/10.1016\/j.tibs.2008.05.006.","journal-title":"Trends in biochemical sciences"},{"issue":"16","key":"8210_CR30","doi-asserted-by":"publisher","first-page":"3750","DOI":"10.1158\/1078-0432.ccr-14-2650","volume":"21","author":"SC Mack","year":"2015","unstructured":"Mack SC, Agnihotri S, Bertrand KC et al. Spinal Myxopapillary Ependymomas Demonstrate a Warburg Phenotype. Clinical cancer research\u202f: an official journal of the American Association for Cancer Research 2015;21:3750\u20133758. https:\/\/doi.org\/10.1158\/1078-0432.ccr-14-2650.","journal-title":"Clinical cancer research : an official journal of the American Association for Cancer Research"},{"key":"8210_CR31","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.semcancer.2018.09.002","volume":"57","author":"Z Dong","year":"2019","unstructured":"Dong Z, Cui H. Epigenetic modulation of metabolism in glioblastoma. Seminars in cancer biology 2019;57:45\u201351. https:\/\/doi.org\/10.1016\/j.semcancer.2018.09.002.","journal-title":"Seminars in cancer biology"},{"issue":"2","key":"8210_CR32","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/bpa.12022","volume":"23","author":"S Venneti","year":"2013","unstructured":"Venneti S, Thompson CB. Metabolic modulation of epigenetics in gliomas. Brain pathology (Zurich, Switzerland) 2013;23:217\u2013221. https:\/\/doi.org\/10.1111\/bpa.12022.","journal-title":"Brain pathology (Zurich, Switzerland)"},{"issue":"1","key":"8210_CR33","doi-asserted-by":"publisher","first-page":"5","DOI":"10.5732\/cjc.010.10542","volume":"30","author":"J Wykosky","year":"2011","unstructured":"Wykosky J, Fenton T, Furnari F, Cavenee WK. Therapeutic targeting of epidermal growth factor receptor in human cancer: successes and limitations. Chinese journal of cancer 2011;30:5\u201312. https:\/\/doi.org\/10.5732\/cjc.010.10542.","journal-title":"Chinese journal of cancer"},{"issue":"7184","key":"8210_CR34","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/nature06734","volume":"452","author":"HR Christofk","year":"2008","unstructured":"Christofk HR, Vander Heiden MG, Harris MH, Ramanathan A, Gerszten RE, Wei R, Fleming MD, Schreiber SL, Cantley LC. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 2008;452:230\u2013233. https:\/\/doi.org\/10.1038\/nature06734.","journal-title":"Nature"},{"issue":"7375","key":"8210_CR35","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/nature10598","volume":"480","author":"W Yang","year":"2011","unstructured":"Yang W, Xia Y, Ji H et al. Nuclear PKM2 regulates \u03b2-catenin transactivation upon EGFR activation. Nature 2011;480:118\u2013122. https:\/\/doi.org\/10.1038\/nature10598.","journal-title":"Nature"},{"key":"8210_CR36","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.biocel.2015.01.022","volume":"63","author":"S Vidali","year":"2015","unstructured":"Vidali S, Aminzadeh S, Lambert B et al. Mitochondria: The ketogenic diet\u2013A metabolism-based therapy. Int J Biochem Cell Biol 2015;63:55\u201359. https:\/\/doi.org\/10.1016\/j.biocel.2015.01.022.","journal-title":"Int J Biochem Cell Biol"},{"issue":"4","key":"8210_CR37","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.3892\/mmr.2020.10993","volume":"21","author":"X Wang","year":"2020","unstructured":"Wang X, Lai S, Ye Y et al. Conditional knockout of pyruvate dehydrogenase in mouse pancreatic \u03b2-cells causes morphological and functional changes. Molecular medicine reports 2020;21:1717\u20131726. https:\/\/doi.org\/10.3892\/mmr.2020.10993.","journal-title":"Molecular medicine reports"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-023-08210-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-023-08210-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-023-08210-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T18:22:27Z","timestamp":1707762147000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-023-08210-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,3]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["8210"],"URL":"https:\/\/doi.org\/10.1007\/s10620-023-08210-x","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,3]]},"assertion":[{"value":"16 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors declared that they have not any conflicts of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All the animal experiments were performed according to the animal ethics committee of Armed Police Coast Guard Corps Hospital with ethical approvement (202016).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}